Maddalena Adorno is an entrepreneur and a biomedical scientist with a focus on Stem Cell, Aging and Regenerative Medicine. She is the co-founder and CEO of Dorian Therapeutics, (www.doriantherapeutics.com) and the main inventor of the senoblocker technology that the company is pursuing. She is also an Instructor at Stanford Continuing Studies for a popular class in Longevity and Aging.
Related Organizations
Articles from this author
September 17, 2025
[Mountain View, September 17, 2025] — Lifespan Research Institute (LRI) today announced the launch of the Public Longevity Group (PLG), a new initiative focused on bridging the cultural gap between scientific breakthroughs in aging and their public acceptance. To kickstart its work, PLG has opened a crowdfunding campaign to develop tools that measure and strengthen...

